| Recruiting | A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | 2025-09-01 |
| Unknown | Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Allergic Rhinitis Due to House Dust Mite, Allergic Asthma | — | 2023-11-21 |
| Unknown | The Effect of Allergic Rhinitis on Educational Outcomes Allergic Rhinitis | — | 2023-02-15 |
| Completed | Observational Study of Allergic Rhinitis in Children Allergic Rhinitis | — | 2022-11-23 |
| Active Not Recruiting | Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy Peanut Allergy | Phase 1 / Phase 2 | 2022-09-07 |
| Unknown | Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rh Allergy, Allergic Rhinitis, Asthma | — | 2022-04-01 |
| Completed | A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis Allergy | Phase 3 | 2021-05-10 |
| Completed | A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis Allergy | Phase 3 | 2021-04-07 |
| Completed | Adolescent Mite Allergy Safety Evaluation Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | 2020-09-23 |
| Terminated | A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber Allergic Rhinoconjunctivitis | Phase 3 | 2019-11-04 |
| Completed | House Dust Mite Allergy Trial In Children Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis Due to House Dust Mite | Phase 3 | 2019-10-12 |
| Completed | Impact of AIT on Allergic Rhinitis and Asthma Allergy, Respiratory Disease | — | 2019-07-22 |
| Completed | N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France Allergic Rhinitis Due to House Dust Mite, Allergic Asthma Due to Dermatophagoides Farinae, Allergic Asthma Due to Dermatophagoides Pteronyssinus | — | 2018-05-09 |
| Completed | Mite Asthma Pediatric Immunotherapy Trial Allergic Asthma Due to Dermatophagoides Farinae, Allergic Asthma Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis Due to House Dust Mite | Phase 3 | 2018-02-22 |
| Completed | A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber Allergic Rhinoconjunctivitis | Phase 2 | 2015-06-01 |
| Completed | Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induce Rhinitis, Allergic, Seasonal | Phase 4 | 2014-10-01 |
| Completed | Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis Duri Grass Pollen Induced Allergic Rhinoconjunctivitis | Phase 2 | 2014-06-01 |
| Completed | An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy Allergic Rhinoconjunctivitis | Phase 2 | 2014-04-01 |
| Completed | An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy Allergic Rhinoconjunctivitis Due to Salsola Kali Pollen | Phase 2 | 2013-12-01 |
| Completed | Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate Allergic Rhinitis Due to Grass Pollens | Phase 4 | 2013-04-01 |
| Completed | Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic R Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal | Phase 3 | 2013-01-01 |
| Completed | A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy Allergic Rhinitis | Phase 2 | 2012-11-01 |
| Completed | Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal | Phase 1 | 2012-10-01 |
| Completed | A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Indu Rhinitis, Allergic, Perennial, Rhinitis, Allergic, Nonseasonal | Phase 2 | 2012-10-01 |
| Completed | An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy Allergic Rhinitis Due to Olea Europaea Pollen | Phase 2 / Phase 3 | 2012-09-01 |
| Completed | A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet Birch Pollen Allergy | Phase 2 | 2012-08-01 |
| Completed | A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021) Allergic Rhinoconjunctivitis | — | 2012-01-01 |
| Completed | An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy Allergic Rhinitis Due to Dust Mite | Phase 2 / Phase 3 | 2011-12-01 |
| Completed | A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P0 Allergy | Phase 3 | 2011-11-01 |
| Completed | Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) Perennial Allergic Rhinitis, Seasonal Allergic Rhinitis | — | 2011-11-01 |
| Completed | A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet House Dust Mite Allergy | Phase 3 | 2011-10-01 |
| Completed | Avanz Phleum Pratense Maintenance Dose Allergic Rhinoconjunctivitis | Phase 2 / Phase 3 | 2011-09-01 |
| Completed | Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense Rhino-conjunctivitis | Phase 2 | 2011-08-01 |
| Completed | House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma Asthma | Phase 3 | 2011-08-01 |
| Completed | A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) Rhinitis Allergic, Conjunctivitis | Phase 3 | 2011-06-01 |
| Completed | An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy Allergic Rhinoconjunctivitis | Phase 2 / Phase 3 | 2011-06-01 |
| Terminated | Comparison of Different Up-dosing Schedules With Osiris Allergic Rhinitis | Phase 2 | 2010-12-01 |
| Completed | Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch Allergy | Phase 2 | 2010-01-01 |
| Completed | Grazax Asthma Prevention Allergic Rhinitis | Phase 3 | 2010-01-01 |
| Completed | Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) Rhinoconjunctivitis, Rhinitis, Conjunctivitis | Phase 2 | 2009-11-01 |
| Completed | Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis Allergic Rhinitis | Phase 3 | 2009-10-01 |
| Completed | Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History Rhinitis; Allergic, With Asthma, Conjunctivitis | Phase 2 / Phase 3 | 2009-09-01 |
| Completed | Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults Wit Rhinitis, Allergic, Conjunctivitis | Phase 2 / Phase 3 | 2009-09-01 |
| Completed | Exposure Chamber Trial With Cat Immunotherapy Cat Allergy | Phase 2 | 2009-09-01 |
| Completed | Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX® Allergic Rhinoconjunctivitis | Phase 4 | 2009-09-01 |
| Completed | Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic P Rhinitis, Conjunctivitis, Asthma | Phase 2 | 2009-02-01 |
| Completed | A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine Allergic Rhinoconjunctivitis | Phase 3 | 2008-09-01 |
| Completed | Intraseasonal Short-time Up-dosing With Alutard SQ Grasses Allergy | Phase 3 | 2008-04-01 |
| Completed | A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment Grass Pollen Allergy | Phase 3 | 2008-04-01 |
| Completed | Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) Rhinoconjunctivitis, Rhinitis, Conjunctivitis | Phase 3 | 2007-11-01 |
| Completed | Tolerability of Grazax in Patients With Hayfever in Real Life Settings Allergic Rhinoconjunctivitis | Phase 4 | 2007-11-01 |
| Completed | Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) Rhinoconjunctivitis, Rhinitis, Conjunctivitis | Phase 3 | 2007-11-01 |
| Completed | Tolerability of ALK Tree Tablet Allergy | Phase 1 | 2007-10-01 |
| Completed | Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis Allergic Rhinitis, Grass Allergy | Phase 3 | 2007-03-01 |
| Completed | Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Ta Allergy | Phase 3 | 2007-01-01 |
| Completed | A Trial of Grazax in Subjects With Hayfever Allergy | Phase 3 | 2006-12-01 |
| Completed | Efficacy and Safety of Grazax in Children Allergy | Phase 3 | 2006-11-01 |
| Completed | Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma Allergic Asthma | Phase 4 | 2006-10-01 |
| Completed | Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects Asthma | Phase 2 / Phase 3 | 2006-08-01 |
| Completed | Efficacy of SLITone in House Dust Mite Allergic Patients Allergy | Phase 2 / Phase 3 | 2006-07-01 |
| Completed | Safety of ALK Ragweed Tablet Allergy | Phase 1 | 2006-05-01 |
| Completed | Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2006-04-01 |
| Completed | Tolerability of ALK Grass Tablet in Children Allergy | Phase 1 | 2006-03-01 |
| Completed | Assessment of Grazax® Treatment Compliance Allergy | Phase 3 | 2006-02-01 |
| Completed | Tolerability of Grazax-R in Children Allergy | Phase 1 | 2006-02-01 |
| Completed | Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever Allergy | Phase 3 | 2005-06-01 |
| Completed | A Trial of the ALK Grass Tablet in Subjects With Hayfever Allergy | Phase 3 | 2004-10-01 |